Image via Wikipedia
It raises hopes that kidney disease patients will one day be able to grow their own new organs with no risk of rejection.
Kidneys 5mm long – the size of those in foetuses – were made using a combination of cells from amniotic fluid, which surrounds babies in the womb, and animal foetal cells.
It is hoped the organs could be grown to maturity if implanted in a patient. In future, people’s amniotic fluid could be retained at birth, allowing it to be used later if they develop kidney disease.
‘The idea is to start with human
Researchers at Johns Hopkins have found a better way to create induced pluripotent stem (iPS) cells—adult cells reprogrammed with the properties of embryonic stem cells—from a small blood sample. This new method, described last week in Cell Research, avoids creating DNA changes that could lead to tumor formation.
“These iPS cells are much safer than ones made with previous technologies because they don’t involve integrating foreign viruses that can potentially lead to uncontrolled, cancerous cell growth,” says Linzhao Cheng, Ph.D., an associate professor of medicine in the Division of Hematology and a
In a major achievement, the scientists have managed to get a patent for growing stem cells of the cornea. The cells will be grown on a synthetic material, called Mebiol Gel, which will be used in the process of transplant.
For a long time scientists across the world have been trying to get the patent. The declaration was made by the researchers at Sankara Nethralaya and Nichi-In Biosciences Sankara Nethralaya and Nichi-In Biosciences on Friday.
The new procedures have been devised and patented by these two institutes. A synthetic substance was used by the researchers for growing the corneal limbal stem
Patients before and after Regenexx stem cell procedure educational video showing how it is done and patient’s results for knees and hips…
Local News does story on stem cell patient who received the regenexx procedure…
Making a breakthrough in the battle against breast cancer, scientists have used a combination of drugs to target cancer stem cells that cause the disease to spread.
Current treatments kill only the surface cells in a breast tumour, but scientists now say they can destroy the root, the Mirror reported.
They hope that the findings, revealed ahead of World Cancer Day, can be used to help women with advanced and aggressive cancers. Targeting cancer stem cells takes us a step closer to better clinical options for those with the disease, said Dr Rob Clarke, of Manchester University.